News
Category
-
Business Wire
AtlantiCare Expands Consumer Self-Service with Digital Access Solutions from Kyruus
July 20, 2021 -
Endpoints News
As its next big bet, Sana inks long-term lease for manufacturing site for next-gen cell therapies
July 15, 2021 -
PR Newswire
Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI319 (Anti-PD-1/CD137 Bispecific Antibody) in Patients with Advanced Malignant Tumors
July 15, 2021 -
PR Newswire
Innovent and Ascentage Pharma Reach Multifaceted Strategic Agreement including Joint Commercialization of Olverembatinib in China, Joint Clinical Development on Multiple Products, and Equity Investment
July 14, 2021 -
Business Wire
Devoted Health Announces Maine Office Expansion, Creating at Least 40 New Jobs in Cumberland County
July 14, 2021 -
TechCrunch
Castor, a clinical trial process company, raises $45M to create more human-centered research
July 14, 2021 -
Forbes
Prime Medicine – This Gene Editing Startup Raised $315 Million For A Next Generation Crispr Tool To Cure Rare Diseases
July 13, 2021 -
GlobeNewswire
Ultragenyx Announces Mepsevii® (vestronidase alfa) Receives Reimbursement Approval for Treatment of Mucopolysaccharidosis VII in Spain
July 13, 2021 -
Business Wire
Stamford Health Chooses PatientPing’s Route Solution to Achieve E-Notifications CoP Compliance Under CMS’s Interoperability and Patient Access Rule
July 13, 2021 -
PR Newswire
Everest Medicines Announces Strategic Collaboration with Medbanks Health Technology to Develop Innovative Healthcare Service Solutions for Patients in China
July 13, 2021 -
Business Wire
Caribou Biosciences Announces Dosing of First Patient in Phase 1 Clinical Trial Evaluating CB-010, a CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients with Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
July 12, 2021 -
Endpoints News
WHO issues new guidelines for gene editing; Doudna-backed Caribou launches its first allogeneic CAR-T trial
July 12, 2021 -
PR Newswire
Innovent Announces NMPA Acceptance of New Drug Application for the FGFR1/2/3 Inhibitor (Pemigatinib) for the Treatment of Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement
July 8, 2021 -
PR Newswire
Innovent and Laekna Therapeutics Enter a Partnership Agreement to Co-Develop Combination Therapy of Sintilimab and Afuresertib in Clinical Studies in China
July 5, 2021 -
Renaissance Capital Report
Cell analysis instruments provider Cytek BioSciences files for a $100 million IPO
July 2, 2021 -
Business Wire
Rallybio Announces Clinical Proof of Concept for RLYB211, an Anti-HPA-1a Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
July 2, 2021 -
GlobeNewswire
Significant Continued Progress with Formulary Uptake of BARHEMSYS® and BYFAVO™ in the US
July 1, 2021 -
MarketWatch
Caribou Biosciences files for IPO to help fund drug studies
July 1, 2021 -
GlobeNewswire
Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo autologous HSC Gene Therapy for Hereditary Angioedema
July 1, 2021 -
GlobeNewswire
Apellis and Beam Therapeutics Enter Exclusive Research Collaboration to Apply Base Editing to Discover Novel Therapies for Complement-Driven Diseases
June 30, 2021 -
GlobeNewswire
Carrot Fertility and RESOLVE Uncover Fertility and Family-Forming Trends in New Fertility at Work Study
June 30, 2021 -
GlobeNewswire
Ultragenyx Appoints Corsee Sanders, Ph.D., to Board of Directors
June 30, 2021 -
Business Wire
Turnstone Biologics Appoints Stewart Abbot, Ph.D., as Chief Scientific Officer
June 29, 2021 -
Business Wire
Precision BioSciences and SpringWorks Therapeutics Dose First Patient in Expanded Phase 1/2a Clinical Trial Evaluating PBCAR269A with Nirogacestat in Patients with Relapsed/Refractory Multiple Myeloma
June 28, 2021 -
PR Newswire
Protenus Announces Nick Culbertson Is an EY Entrepreneur of the Year® 2021 Mid-Atlantic Award Finalist
June 28, 2021 -
PR Newswire
Innovent Announces License Agreement with Synaffix in an ADC Technology Deal
June 28, 2021 -
GlobeNewswire
Denali Therapeutics Announces Initiation of Phase 2 Study by Partner Sanofi of RIPK1-Inhibitor DNL758 (SAR443122) in Cutaneous Lupus Erythematosus (CLE) Patients
June 28, 2021 -
PR Newswire
Innovent Announces the China NMPA Approval of TYVYT® (sintilimab injection) in Combination with BYVASDA® (bevacizumab biosimilar injection) as First-Line Therapy for People with Hepatocellular Carcinoma
June 27, 2021 -
PR Newswire
Innovent Announces the China NMPA Approval of TYVYT® (sintilimab injection) in Combination with BYVASDA® (bevacizumab biosimilar injection) as First-Line Therapy for People with Hepatocellular Carcinoma
June 27, 2021 -
FierceBiotech
Boston Scientific shells out a hearty $295M for Farapulse’s electric-field-generating afib treatment
June 24, 2021 -
GlobeNewswire
Adela Debuts with $60M in Series A Financing and a Breakthrough Approach to Blood-Based Detection of Cancer and Other Diseases
June 23, 2021 -
PR Newswire
Innovent Announces the Approval of Pemazyre® (pemigatinib) in Taiwan Market for the Treatment of Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement
June 21, 2021 -
GlobeNewswire
Verve Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 21, 2021 -
Business Wire
Xilio Therapeutics Announces FDA Acceptance of IND Application for XTX101 for the Treatment of Solid Tumors
June 17, 2021 -
Economic Times
PharmEasy valued at $1.8 billion as B Capital buys stake for $20 million
June 17, 2021 -
MarketWatch
Verve Therapeutics shares soar 68% in trading debut
June 17, 2021 -
Business Wire
Zus Health Closes $34M Series A Led by Andreessen Horowitz (a16z); Participation from F-Prime Capital, Maverick Ventures and Others
June 17, 2021 -
PR Newswire
FDA Approves Blueprint Medicines’ AYVAKIT™ (avapritinib) for the Treatment of Adults with Advanced Systemic Mastocytosis
June 16, 2021 -
PR Newswire
Protenus Raises Series D After Doubling Revenue While Reducing Risk for Health Systems
June 15, 2021 -
Business Wire
Beacon Health System Enhances How Patients Find and Schedule Care with Kyruus’ Digital Platform
June 15, 2021 -
PR Newswire
Innovent Announces First Overweight or Obese Subject Dosed in A Phase 2 Clinical Trial of IBI362 (a GLP-1 and Glucagon Receptor Dual Agonist) in China
June 15, 2021 -
Business Wire
Iora Health and Devoted Health Partner in Houston
June 14, 2021 -
Seeking Alpha
Verve Therapeutics Prepares $201 Million IPO
June 14, 2021 -
Business Wire
Equality Health Launches Partnership with Devoted Health
June 14, 2021 -
GlobeNewswire
GeneTx and Ultragenyx Receive Approval from U.K. Regulatory Agency to Begin Clinical Study of GTX-102 for the Treatment of Angelman Syndrome
June 10, 2021 -
TechCrunch
Whatfix nabs $90M to help workers onboard and get the most out of their IT stacks
June 8, 2021 -
One Medical
One Medical Announces Agreement to Acquire Iora Health
June 7, 2021 -
Forbes
Beam Therapeutics Cofounder And Crispr Scientist Publishes Research On New Sickle Cell Treatment In Mice
June 2, 2021 -
PR Newswire
Clinical Trial Results of the BCMA CAR-T Co-developed by Innovent and IASO Biotherapeutics Commented in American Society of Hematology’s Medical Journal “Blood”
June 2, 2021 -
GlobeNewswire
Zenflow Announces $24 Million Financing Round; Appoints Susan Stimson as President
June 2, 2021 -
Business Wire
Verve Therapeutics Appoints Leading Biotechnology Executive Michael MacLean to its Board of Directors
June 1, 2021 -
PR Newswire
Owkin Bolsters Senior Team With Experienced Pharma Executives to Expand Platform and Strategic Partnerships
June 1, 2021 -
PR Newswire
Vestwell Partners with Wealthtech API Provider Bambu to Expand Investment Advice in Retirement Journey
June 1, 2021 -
Business Wire
Precision BioSciences Announces New Study Published in Nature Communications Using Engineered ARCUS Nuclease to Target Mutant Mitochondrial DNA In Vivo
June 1, 2021 -
PR Newswire
Innovaccer Partners With PatientPing to Empower Physicians With Real-Time Care Coordination
June 1, 2021 -
GlobeNewswire
AnHeart Therapeutics and Innovent Biologics Announce Exclusive License Agreement for Taletrectinib in Greater China
May 31, 2021 -
GlobeNewswire
Flywire Corporation Closes IPO and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 28, 2021 -
Renaissance Capital Report
Gene editing biotech Verve Therapeutics files for a $100 million IPO
May 28, 2021 -
GlobeNewswire
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945
May 27, 2021 -
PR Newswire
NFlection Therapeutics’ NFX-179 Gel Demonstrates Safety and Significant Reduction in p-ERK, a Key Biomarker Driving Neurofibroma Tumor Growth, in Positive Data From a 28-Day Phase 2a Clinical Trial
May 26, 2021 -
The Real Deal
Digital mortgage platform Snapdocs valued at more than $1B
May 26, 2021 -
GlobeNewswire
Singular Genomics Systems, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock
May 26, 2021 -
GlobeNewswire
Apellis and Sobi Report Positive Top-line Results from the Phase 3 PRINCE Study of EMPAVELI™ (pegcetacoplan) in Treatment-naïve Patients with PNH
May 25, 2021 -
Business Wire
Xilio Therapeutics Announces Clinical Trial Collaboration With Merck on Anti-CTLA-4 Monoclonal Antibody Program
May 25, 2021 -
GlobeNewswire
Flywire Announces Pricing of Initial Public Offering
May 25, 2021 -
PR Newswire
Innovent Announces First Patient Dosed in China in the Global Phase 3 Clinical Trial of Pemigatinib as the First-line Treatment of Unresectable or Metastatic Cholangiocarcinoma
May 24, 2021 -
Business Wire
Xilio Therapeutics to Present Preclinical Data Highlighting Anti-Tumor Activity and Tolerability of XTX202 at the 2021 ASCO Annual Meeting
May 20, 2021 -
GlobeNewswire
GeneTx and Ultragenyx Receive Clearance from Health Canada to Begin Clinical Study of GTX-102 in Canada for the Treatment of Angelman Syndrome
May 19, 2021 -
GlobeNewswire
Adagene Presents Clinical Data from NEObody™ Program, ADG106, Anti-CD137 Agonist, in an Abstract at ASCO 2021 Annual Meeting
May 19, 2021 -
FierceBiotech
ASCO: Adaptimmune’s cell therapy shrinks 39% of rare sarcomas
May 19, 2021 -
GlobeNewswire
Flywire Launches Roadshow for Proposed Initial Public Offering
May 18, 2021 -
PR Newswire
U.S. FDA Accepts Regulatory Submission for Sintilimab in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of People with Nonsquamous Non-Small Cell Lung Cancer
May 18, 2021 -
PR Newswire
LunaPBC Announces Joe Beery as New Chief Executive Officer
May 18, 2021 -
PR Newswire
Protenus Selected as One of the Best Places to Work in Healthcare for Fourth Straight Year
May 17, 2021 -
Business Wire
Caribou Biosciences Announces Appointment of Katy Rezvani, M.D., Ph.D. and Christopher Sturgeon, Ph.D. to its Scientific Advisory Board
May 17, 2021 -
PR Newswire
Innovent Will Publish Multiple Clinical Data at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
May 16, 2021 -
GlobeNewswire
Ultragenyx Announces Positive Multi-Year Durability Data from Ongoing Phase 1/2 Gene Therapy Studies and Data on HeLa 3.0 Manufacturing Platform at American Society of Gene & Cell Therapy 2021 Annual Meeting
May 14, 2021 -
GlobeNewswire
Apellis Announces U.S. Food and Drug Administration (FDA) Approval of EMPAVELI™ (pegcetacoplan) for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)
May 14, 2021 -
GlobeNewswire
Affinia Therapeutics Presents New Data and Updates on AAV Platform at American Society of Gene and Cell Therapy Annual Meeting
May 13, 2021 -
Business Wire
Xilio Therapeutics Presents Preclinical Tumor-Selective Activity and Tolerability Data for XTX101 at Frontiers in Cancer Immunotherapy Virtual Symposium
May 12, 2021 -
PR Newswire
Citrine Medicine Announces Strategic Partnership to bring Efmody® to China for Use in Adrenal Insufficiency (AI), including Congenital Adrenal Hyperplasia (CAH)
May 12, 2021 -
GlobeNewswire
First Preclinical Data from Adaptimmune’s Mesothelin HiT Program at ASGCT Demonstrate Antigen-specific Tumor Cell Killing in vitro and Complete Tumor Regression in an Animal Model
May 11, 2021 -
GlobeNewswire
Orchard Therapeutics Announces New England Journal of Medicine Publication of HSC Gene Therapy Data for ADA-SCID
May 11, 2021 -
GlobeNewswire
Beam Therapeutics Presents LNP Formulation Data at ASGCT and Reports First Quarter 2021 Financial Results
May 11, 2021 -
Reuters
Nio Lidar supplier Innovusion raises $64 million in funding
May 11, 2021 -
GlobeNewswire
Checkmate Pharmaceuticals Announces Clinical Supply Agreement with Regeneron to Evaluate Vidutolimod (CMP-001) in Combination with Libtayo® (cemiplimab)
May 10, 2021 -
Renaissance Capital Report
Singular Genomics Systems, a developer of next-gen sequencing tech, files for a $100 million IPO
May 7, 2021 -
Business Wire
Turnstone Biologics Announces Executive Leadership Promotions and Board Appointment
May 7, 2021 -
Denali Therapeutics Presents Positive Results from Phase 1 and Phase 1b Studies of Its LRRK2 Inhibitor, BIIB122/DNL151, Supporting Late-Stage Development Plans in Parkinson’s Disease
May 6, 2021 -
PR Newswire
Whatfix Announces Partnership with C-Clear Partners In Europe to Help Organizations Bolster Digital Transformation
May 6, 2021